Sequencing of circulating tumor DNA from cancer patients is a cost-efficient approach with turnaround time compatible with clinical practice to inform treatment decision-making in a phase 1 trial setting
- Dominic G. Rothwell
- Mahmood Ayub
- Matthew G. Krebs